Director, clinical pharmacology best companies
The best companies for directors, clinical pharmacology to work for in 2024 are Pfizer and Verastem Oncology. If you are looking for the best-paying companies for directors, clinical pharmacology, you should consider Neurocrine Biosciences with a median director, clinical pharmacology salary of $150,617 or Verastem Oncology with a median salary of $146,618.
10 best companies for Directors, clinical pharmacology
Zippia score 4.5
Average director, clinical pharmacology salary: $122,637
#1 top company for directors, clinical pharmacologyCompany description:Good health is vital to all of them , and finding sustainable solutions to the most pressing health care challenges of their world cannot wait. That's why they at Pfizer are committed to applying science and their global resources to improve health and well-being at every stage of life. They strive to provide access to safe, effective and affordable medicines and related health care services to the people who need them. They have a leading portfolio of products and medicines that support wellness and prevention, as well as treatment and cures for diseases across a broad range of therapeutic areas; and they have an industry-leading pipeline of promising new products that have the potential to challenge some of the most feared diseases of their time, like Alzheimer's disease and cancer.
- Learn more about Pfizer:
- Pfizer overview
- Pfizer salaries
- Pfizer jobs
Zippia score 3.7
Average director, clinical pharmacology salary: $146,618
#2 top company for directors, clinical pharmacologyCompany description:ThePoliticalGuide.com is political guide intended to provide impartial information on candidates, elections, and representatives.
- Learn more about Verastem Oncology:
- Verastem Oncology overview
- Verastem Oncology salaries
Zippia score 4.6
Average director, clinical pharmacology salary: $135,729
#3 top company for directors, clinical pharmacologyCompany highlights:AstraZeneca is one of the world's leading pharmaceutical companies. It focuses on the discovery, development and commercialisation of prescription medicines. Its purpose is to deliver life-changing medicines by pushing the boundaries of science. AstraZenesa specializes in three main therapy areas Oncology, Cardiovascular & Metabolic Disease (CVMD) and Respiratory. The company operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. Its headquarters in North America are located in Wilmington, DE, with additional locations in Gaithersburg, MD, and Boston, MA.
- Learn more about AstraZeneca:
- AstraZeneca overview
- AstraZeneca salaries
- AstraZeneca jobs
Zippia score 4.5
Average director, clinical pharmacology salary: $123,527
#4 top company for directors, clinical pharmacologyCompany description:Gilead Sciences, Inc. is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines.
- Learn more about Gilead Sciences:
- Gilead Sciences overview
- Gilead Sciences salaries
- Gilead Sciences jobs
Zippia score 4.6
Average director, clinical pharmacology salary: $57,449
#5 top company for directors, clinical pharmacologyCompany description:Tufts University is a private research university on the border of Medford and Somerville, Massachusetts.
- Learn more about Tufts University:
- Tufts University overview
- Tufts University salaries
- Tufts University jobs
Zippia score 4.6
Average director, clinical pharmacology salary: $127,825
#6 top company for directors, clinical pharmacologyCompany description:Bristol-Myers Squibb Company, through its subsidiaries, engages in the discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceuticals and nutritional products. The company operates in two segments, Pharmaceuticals and Nutritionals. - The Nutritionals segment is operated through the company's subsidiary Mead Johnson Nutrition Company (Mead Johnson). - The Pharmaceuticals segment is made up of the global pharmaceutical and international consumer medicines business.
- Learn more about Bristol-Myers Squibb:
- Bristol-Myers Squibb overview
- Bristol-Myers Squibb salaries
- Bristol-Myers Squibb jobs
Zippia score 4.4
Average director, clinical pharmacology salary: $135,196
#7 top company for directors, clinical pharmacologyCompany highlights:Covance Inc. is a global contract research organization recognized for being the world's most comprehensive drug development company. It has a team of professionals that are dedicated to advancing healthcare and delivering fast and innovative medical solutions to patients and healthcare providers. The company also offers laboratory testing services to the chemical, agrochemical, and food industries. It is also a market leader in central laboratory, toxicology, and discovery services.
- Learn more about Covance:
- Covance overview
- Covance salaries
- Covance jobs
Zippia score 4.6
Average director, clinical pharmacology salary: $133,085
#8 top company for directors, clinical pharmacologyCompany description:CH Boehringer Sohn AG & Ko. KG is the parent company of the Boehringer Ingelheim group, which was founded in 1885 by Albert Boehringer in Ingelheim am Rhein, Germany.
- Learn more about Boehringer Ingelheim:
- Boehringer Ingelheim overview
- Boehringer Ingelheim salaries
- Boehringer Ingelheim jobs
Zippia score 4.0
Average director, clinical pharmacology salary: $95,802
#9 top company for directors, clinical pharmacologyCompany description:St. Jude is leading the way the world understands, treats and defeats childhood cancer and other life-threatening diseases.
- Learn more about St. Jude Children's Research Hospital:
- St. Jude Children's Research Hospital overview
- St. Jude Children's Research Hospital salaries
- St. Jude Children's Research Hospital jobs
Zippia score 4.7
Average director, clinical pharmacology salary: $111,148
#10 top company for directors, clinical pharmacologyCompany description:Johnson & Johnson engages in the research and development, manufacture, and sale of a range of products in the healthcare field. The company operates through three business segments, including Consumer; Pharmaceutical and Medical Devices; and Diagnostics. The Consumer segment includes a range of products used in the baby care, skin care, oral care, wound care and women's health care fields, as well as nutritional and over-the-counter pharmaceutical products. The Baby Care franchise includes the JOHNSON'S Baby line of products. Major brands in the Skin Care franchise include the AVEENO; CLEAN & CLEAR; JOHNSON'S Adult; NEUTROGENA; RoC; LUBRIDERM; Beijing Dabao Cosmetics Co., Ltd.; and Vendome product lines. The Oral Care franchise includes the LISTERINE and REACH oral care lines of products. Major brands in the Women's Health franchise are the CAREFREE Pantiliners and STAYFREE sanitary protection products. The nutritional and over-the-counter lines include SPLENDA, No Calorie Sweetener; the family of TYLENOL acetaminophen products; SUDAFED cold, flu and allergy products; ZYRTEC allergy products; MOTRIN IB ibuprofen products; and PEPCID AC Acid Controller from Johnson & Johnson Merck Consumer Pharmaceuticals Co. These products are marketed principally to the general public and sold both to wholesalers and directly to independent and chain retail outlets throughout the world. Pharmaceutical The Pharmaceutical segment includes products in the following therapeutic areas: anti-infective, antipsychotic, cardiovascular, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, urology and virology. These products are distributed directly to retailers, wholesalers and health care professionals for prescription use by the general public. Key products in the Pharmaceutical segment include: REMICADE (infliximab), a biologic approved for the treatment of Crohn's disease, ankylosing spondylitis, psoriasis, psoriatic arthritis, ulcerative colitis, and use in the treatment of rheumatoid arthritis; TOPAMAX (topiramate), approved for adjunctive and monotherapy use in epilepsy, as well as for the prophylactic treatment of migraines; PROCRIT (Epoetin alfa, sold outside the U.S. as EPREX), a biotechnology-derived product that stimulates red blood cell production; RISPERDAL oral (risperidone), a medication that treats the symptoms of schizophrenia, bipolar mania and irritability associated with autistic behavior in indicated patients, RISPERDAL CONSTA (risperidone), a long-acting injectable, and INVEGA (paliperdone) Extended-Release tablets, for the treatment of schizophrenia; LEVAQUIN (levofloxacin) and FLOXIN (ofloxacin), both in the anti-infective field; CONCERTA (methylphenidate HCl), a product for the treatment of attention deficit hyperactivity disorder; ACIPHEX/PARIET, a proton pump inhibitor co-marketed with Eisai Inc.; and DURAGESIC/Fentanyl Transdermal (fentanyl transdermal system, sold outside the U.S. as DUROGESIC), a treatment for chronic pain that offers a novel delivery system. Medical Devices and Diagnostics The Medical Devices and Diagnostics segment includes a range of products distributed to wholesalers, hospitals and retailers, used principally in the professional fields by physicians, nurses, therapists, hospitals, diagnostic laboratories and clinics. These products include Cordis' circulatory disease management products; DePuy's orthopaedic joint reconstruction, spinal care and sports medicine products; Ethicon's surgical care and women's health products; Ethicon Endo-Surgery's minimally invasive surgical products; LifeScan's blood glucose monitoring and insulin delivery products; Ortho-Clinical Diagnostics' professional diagnostic products and Vistakon's disposable contact lenses.
- Learn more about Johnson & Johnson:
- Johnson & Johnson overview
- Johnson & Johnson salaries
- Johnson & Johnson jobs
10 highest paying companies for Directors, clinical pharmacology
Zippia score 4.7
Average director, clinical pharmacology salary: $150,617
#1 highest paying company for directors, clinical pharmacologyCompany description:Neurocrine Biosciences engages in the discovery and development of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company develops drugs for endometriosis, anxiety, depression, pain, diabetes, irritable bowel syndrome, insomnia, and other neurological and endocrine related diseases and disorders. Its products in clinical development comprise Elagolix, a Phase II product for Endometriosis; CRF1 Antagonist, a phase II product for mood disorders; CRF2 Peptide Agonist, a phase II drug for Cardiovascular related diseases; CRF1 Antagonist, a Phase I product for treating Mood Disorders and Irritable Bowel Syndrome; and Elagolix, a Phase I product for treating Benign Prostatic Hyperplasia and Uterine Fibroids. The company's research programs include Vesicular Monoamine Transporter 2 Inhibitor for movement disorders and schizophrenia; Glucose Dependent Insulin Secretagogues for type II diabetes; Antiepileptic drugs for epilepsy and bipolar disorder; and GnRH Antagonists for hormone dependent diseases and oncology. It has strategic alliances with GlaxoSmithKline to develop and commercialize CRF antagonists for psychiatric, neurological, and gastrointestinal diseases; and Dainippon Sumitomo Pharma Co. Ltd. to develop and commercialize indiplon in Japan. Neurocrine Biosciences, Inc. was founded in 1992 and is based in San Diego, California.
- Learn more about Neurocrine Biosciences:
- Neurocrine Biosciences overview
- Neurocrine Biosciences salaries
- Neurocrine Biosciences jobs
Zippia score 3.7
Average director, clinical pharmacology salary: $146,618
#2 highest paying company for directors, clinical pharmacologyCompany description:ThePoliticalGuide.com is political guide intended to provide impartial information on candidates, elections, and representatives.
- Learn more about Verastem Oncology:
- Verastem Oncology overview
- Verastem Oncology salaries
Zippia score 4.8
Average director, clinical pharmacology salary: $142,196
#3 highest paying company for directors, clinical pharmacologyCompany description:Learn about who we are, our approach to scientific innovation, our areas of therapeutic focus, our products, commitments and more.
- Learn more about Daiichi Sankyo:
- Daiichi Sankyo overview
- Daiichi Sankyo salaries
- Daiichi Sankyo jobs
Zippia score 4.8
Average director, clinical pharmacology salary: $142,174
#4 highest paying company for directors, clinical pharmacologyCompany description:Alnylam (Nasdaq: ALNY) is the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare genetic, cardio-metabolic, hepatic infectious, and central nervous system (CNS)/ocular diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach for the treatment of a wide range of severe and debilitating diseases.
- Learn more about Alnylam Pharmaceuticals:
- Alnylam Pharmaceuticals overview
- Alnylam Pharmaceuticals salaries
- Alnylam Pharmaceuticals jobs
Zippia score 4.9
Average director, clinical pharmacology salary: $141,246
#5 highest paying company for directors, clinical pharmacologyCompany description:Biogen Idec uses cutting-edge science to discover, develop, manufacture and market biological products for the treatment of serious diseases with a focus on neurological disorders. Founded in 1978, Biogen Idec is the world's oldest independent biotechnology company. Patients worldwide benefit from its leading multiple sclerosis therapies, and the company generates more than $4 billion in annual revenues.
- Learn more about Biogen:
- Biogen overview
- Biogen salaries
- Biogen jobs
Zippia score 4.7
Average director, clinical pharmacology salary: $140,804
#6 highest paying company for directors, clinical pharmacologyCompany description:Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical treatments for metabolic and cardiovascular disease, central nervous system disease, respiratory and immunology, oncology, and general medicine areas. It offers products for the treatment of type II diabetes, hypertension, insomnia, Alzheimer s-type dementia, hyperuricemia and gout, peptic ulcer, acid reflux, multiple myeloma, prostate and breast cancer, endometriosis, cancer, malignant lymphoma, and major depressive disorder diseases. The company was founded in 1998 and is based in Deerfield, Illinois. It has business and sales operations in Europe, the Russian Federation, CIS, Japan, North America, Latin America, Asia, and internationally. Takeda Pharmaceuticals U.S.A., Inc. operates as a subsidiary of Takeda Pharmaceutical Company Limited.
- Learn more about Takeda Pharmaceuticals U.S.A., Inc.:
- Takeda Pharmaceuticals U.S.A., Inc. overview
- Takeda Pharmaceuticals U.S.A., Inc. salaries
- Takeda Pharmaceuticals U.S.A., Inc. jobs
Zippia score 4.7
Average director, clinical pharmacology salary: $138,616
#7 highest paying company for directors, clinical pharmacologyCompany description:Seattle Genetics is a clinical-stage biotechnology company, focuses on developing and commercializing monoclonal antibody-based therapies for the treatment of cancer and autoimmune diseases. Its lead product, SGN-35, is in the pivotal trial for patients with relapsed or refractory Hodgkin lymphoma. The company's other product candidates in various stages of clinical trials include dacetuzumab (SGN-40), a humanized anti-CD40 antibody; lintuzumab (SGN-33), a humanized anti-CD33 antibody; SGN-70, a humanized anti-CD70 antibody for the treatment of autoimmune diseases; SGN-75, which is in Phase I clinical trials for metastatic renal cell carcinoma and non-Hodgkin lymphoma; ASG-5ME, a preclinical antibody-drug conjugate product candidate for the treatment of solid tumors; and SGN-19A, a preclinical antibody-drug conjugate product candidate for the treatment of hematologic malignancies. It has collaborations with Bayer Pharmaceuticals Corporation; Celldex Therapeutics, Inc.; Daiichi Sankyo Co., Ltd.; Genentech; GlaxoSmithKline LLC; MedImmune, Inc.; Millennium; PSMA Development Company LLC; and Genmab A/S. The company also has an antibody-drug conjugates co-development agreement with Agensys, Inc. The company was founded in 1997 and is headquartered in Bothell, Washington.
- Learn more about Seagen:
- Seagen overview
- Seagen salaries
- Seagen jobs
Zippia score 4.8
Average director, clinical pharmacology salary: $136,021
#8 highest paying company for directors, clinical pharmacologyCompany description:Eisai Inc. (pronounced ā-zī) is a U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd, a research-based human health care (hhc) company that discovers, develops and markets products throughout the world. Established in 1995, Eisai Inc. began marketing its first product in the United States in 1997 and has rapidly grown to become an integrated pharmaceutical business. Headquartered in Woodcliff Lake, New Jersey, they are dedicated to a tradition of genuine concern for people and are driven by the desire to help meet the diverse health care needs of patients and their families and caregivers. They are an agile, entrepreneurial organization managed by experienced leadership, backed by the strength, stability and historical successes of Eisai Co., Ltd., which has a strong and lasting commitment to the U.S. market. Their heritage and mission have earned us recognition as an innovative, efficient, solution-oriented pharmaceutical company - a company that effectively works with healthcare professionals, hospitals and managed care organizations to develop and market specialty products that help address unmet needs. Their ability to forge strong alliances gives us a competitive edge. In the United States, their rapid growth and strong performance result from putting patients and their families first when making decisions and from empowering the people who manage their operations. Eisai employees personify their values of integrity, respect, professionalism, quality and teamwork.
- Learn more about Eisai:
- Eisai overview
- Eisai salaries
- Eisai jobs
Zippia score 4.6
Average director, clinical pharmacology salary: $135,729
#9 highest paying company for directors, clinical pharmacologyCompany highlights:AstraZeneca is one of the world's leading pharmaceutical companies. It focuses on the discovery, development and commercialisation of prescription medicines. Its purpose is to deliver life-changing medicines by pushing the boundaries of science. AstraZenesa specializes in three main therapy areas Oncology, Cardiovascular & Metabolic Disease (CVMD) and Respiratory. The company operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. Its headquarters in North America are located in Wilmington, DE, with additional locations in Gaithersburg, MD, and Boston, MA.
- Learn more about AstraZeneca:
- AstraZeneca overview
- AstraZeneca salaries
- AstraZeneca jobs
Zippia score 4.8
Average director, clinical pharmacology salary: $134,543
#10 highest paying company for directors, clinical pharmacologyCompany description:Moderna, Inc. is a Cambridge, Massachusetts-based biotechnology company that is focused on drug discovery and drug development based on messenger RNA. The company creates synthetic mRNA that can be injected into patients to help them create their own therapies.
- Learn more about Moderna:
- Moderna overview
- Moderna salaries
- Moderna jobs
Choose from 10+ customizable director, clinical pharmacology resume templates
Choose from a variety of easy-to-use director, clinical pharmacology resume templates and get expert advice from Zippia’s AI resume writer along the way. Using pre-approved templates, you can rest assured that the structure and format of your director, clinical pharmacology resume is top notch. Choose a template with the colors, fonts & text sizes that are appropriate for your industry.
Top companies for directors, clinical pharmacology in US
| Rank | Company | Avg. Salary | Jobs |
|---|---|---|---|
| 1 | Pfizer | $122,637 | 36 |
| 2 | Verastem Oncology | $146,618 | - |
| 3 | AstraZeneca | $135,729 | 18 |
| 4 | Gilead Sciences | $123,527 | 41 |
| 5 | Tufts University | $57,449 | - |
| 6 | Bristol-Myers Squibb | $127,825 | 30 |
| 7 | Covance | $135,196 | - |
| 8 | Boehringer Ingelheim | $133,085 | 28 |
| 9 | St. Jude Children's Research Hospital | $95,802 | 30 |
| 10 | Johnson & Johnson | $111,148 | 177 |